Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSamsung Medical Center

About this trial

The goal of this clinical trial is to determine whether a mechanical power-based lung-protective ventilation strategy during one-lung ventilation reduces the incidence of postoperative pulmonary complications in adult patients undergoing lung resection surgery.

Mechanical power during pressure-regulated volume control mode is calculated using the formula below.

Mechanical power (J/min) = 0.098 x respiratory rate x tidal volume x (inspiratory airway pressure above positive end-expiratory pressure + positive end-expiratory pressure)

The main questions it aims to answer are:

* Does a mechanical power-based lung-protective ventilation strategy significantly lower the incidence of major postoperative pulmonary complications compared to conventional ventilation? * How does this strategy impact intraoperative hemodynamic and vital profiles (e.g., blood pressure, cardiac output, vasopressor requirements, and blood oxygen saturation) during one-lung ventilation?

Participants will:

* Be randomized to receive either a mechanical power-based lung-protective ventilation strategy or a conventional lung-protective ventilation strategy exclusively during one-lung ventilation. * Be closely monitored for the occurrence of major postoperative pulmonary complications (atelectasis, pneumonia, acute respiratory distress syndrome, and pulmonary aspiration) and adverse events for 1 month postoperatively.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists (ASA) physical status I-III

Elective thoracic surgery requiring lung lobectomy under one-lung ventilation

Age 18 years or older

Written informed consent obtained from the patient

Disqualifiers

Prior history of thoracic surgery

Emergency surgery

Pregnancy or lactation

Known contraindication to one-lung ventilation

Trial design

Treatments tested in this trial

  • Mechanical power-based lung protective ventilation
  • Conventional lung protective ventilation

Treatment groups

164 Participants
are divided into 2 treatment groups

Sponsors and collaborators